Cytotherapy (journal)
.jpg) | |
| Discipline | Cell biology, immunology, stem cells |
|---|---|
| Language | English |
| Edited by | Edwin Horwitz |
| Publication details | |
Former names | Cytokines, Cellular and Molecular Therapy; Cytokines and Molecular therapy |
| History | 1999-present |
| Publisher | Elsevier on behalf of the International Society for Cell & Gene Therapy |
| Frequency | 12/year |
| 5.414 (2020) | |
| Standard abbreviations | |
| ISO 4 | Cytotherapy |
| Indexing | |
| CODEN | CYTRF3 |
| ISSN | 1465-3249 (print) 1477-2566 (web) |
| LCCN | 00243205 |
| OCLC no. | 288963798 |
| Links | |
Cytotherapy is a peer-reviewed medical journal covering the areas of cell and gene therapy. The journal was established in 1999 and is published by Elsevier on behalf of the International Society for Cell & Gene Therapy (ISCT). Cytotherapy is edited by Editor-in-Chief Edwin Horwitz, Managing Editor Kenneth W. Witwer, Commissioning Editor Patrick Hanley, and Assistant Editor Rachel Burga.
Aims and Scope
[edit]The Journal publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell and gene therapy. Cytotherapy publishes articles exploring the following topics:
- Development and/or characterization of novel gene therapies and cell and/or extracellular vesicle (EV)-based therapeutics.
- Design of novel therapeutic approaches employing cell/EV/gene products.
- Mode of action of cell/EV/gene therapies in relevant cell-based and pre-clinical models.
- Identification of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response rates.
- Role of stem/stromal cells and/or EVs in disease pathophysiology.
- Early and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapies.
- Important advances in cell/EV/gene-based product manufacturing and validation.
- Global/regional regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapies.
Abstracting and indexing
[edit]This journal is abstracted and indexed in Science Citation Index Expanded, Current Contents/Clinical Medicine, Current Contents/ Life Sciences, BIOSIS Previews, and MEDLINE/PubMed. According to the Journal Citation Reports, the journal has a 2020 impact factor of 5.414.[1]
References
[edit]- ↑ "Journal Citation Reports". Clarivate Analytics. Retrieved 2021-07-07.
External links
[edit]
  | This article about a molecular and cell biology journal is a stub. You can help Wikipedia by adding missing information. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |